Transglutaminase 2 as a therapeutic target for neurological conditions

.

Source: Expert Opinion on Therapeutic Targets - October 15, 2021 Category: Drugs & Pharmacology Authors: Jeffrey W. Keillor Gail V.W. Johnson Source Type: research